Helping people with HIV keep their viral load undetectable
Best practices to improve viral suppression for people with HIV
This project looks at which state programs and policies help people with HIV—especially those with low incomes—stay virally suppressed.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11385905 on NIH RePORTER |
What this research studies
This project looks at how state AIDS Drug Assistance Programs (ADAPs) and other care programs help people like you keep their HIV viral load undetectable. Researchers will use health records and program data, advanced causal inference statistics, and interviews with patients and providers to find which policies and services work best. They will compare different state approaches and focus on people with low incomes who depend on ADAPs. The team aims to identify practical program and policy changes that make it easier to stay on antiretroviral treatment and maintain viral suppression.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV in the United States, especially those with low incomes who rely on state ADAPs or ADAP-subsidized insurance for their medications.
Not a fit: People who already have reliable access to care and stable viral suppression through private insurance or who live outside the U.S. ADAP system may not see direct benefits from ADAP-focused changes.
Why it matters
Potential benefit: If successful, the work could lead to program and policy changes that help more people with HIV stay virally suppressed and reduce new infections.
How similar studies have performed: Previous studies of ADAPs have linked certain policies to better viral suppression and have informed policy changes, but this project applies stronger causal methods and broader qualitative work to strengthen those findings.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Mcmanus, Kathleen Ann — University of Virginia
- Study coordinator: Mcmanus, Kathleen Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.